Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Reckitt ( (GB:RKT) ) has provided an announcement.
Reckitt Benckiser has announced changes to its board, appointing Novartis CFO Harry Kirsch and Smith+Nephew CEO Deepak Nath as non-executive directors effective 1 April 2026, with Kirsch also set to join the audit committee from May. Both bring extensive leadership experience from major global healthcare and consumer companies, bolstering Reckitt’s governance and strategic capabilities.
At the same time, non-executive directors Margherita Della Valle and Mahesh Madhavan will retire from the board on 1 April 2026, marking a significant refresh of Reckitt’s non-executive line-up. Chair Sir Jeremy Darroch highlighted their contributions and underscored the expected value of the new directors’ global business expertise for stakeholders as the group pursues growth in its hygiene, health and nutrition franchises.
The most recent analyst rating on (GB:RKT) stock is a Buy with a £70.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.
Spark’s Take on GB:RKT Stock
According to Spark, TipRanks’ AI Analyst, GB:RKT is a Outperform.
Reckitt’s overall stock score reflects strong financial performance and strategic initiatives that support growth, particularly in emerging markets. While the valuation is a concern, the company’s focus on profitability and shareholder returns through buybacks and dividends enhances its investment appeal.
To see Spark’s full report on GB:RKT stock, click here.
More about Reckitt
Reckitt Benckiser Group plc is a global consumer goods company focused on hygiene, health and nutrition, selling more than 20 million products daily under brands such as Dettol, Durex, Enfamil, Finish, Lysol, Nurofen and Vanish. The group employs around 40,000 people worldwide and targets purpose-led brands, a healthier planet and a fairer society in its core markets.
Average Trading Volume: 1,985,811
Technical Sentiment Signal: Strong Buy
Current Market Cap: £39.02B
Find detailed analytics on RKT stock on TipRanks’ Stock Analysis page.